Cassaday & Co Wealth Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5
Closed -$937 – 1442
2026
Q2
$937 Hold
5
– – ﹤0.01% 1082
2026
Q1
$487 Buy
+5
New +$505 ﹤0.01% 1193

Other funds holding RVMD

Cassaday & Co Wealth Management's RVMD Position: Q3 2026 in Review

Cassaday & Co Wealth Management sold out of Revolution Medicines (RVMD) in Q3 2026, closing a stake of 5 shares — an estimated $937 sold.

Cassaday & Co Wealth Management first reported a position in RVMD in Q1 2026 and held it in 2 quarters. The position peaked at $937 in Q2 2026. 756 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Cassaday & Co Wealth Management reported no remaining Revolution Medicines position as of Q3 2026 after selling out during the quarter.
  • Cassaday & Co Wealth Management sold 5 Revolution Medicines shares in Q3 2026, an estimated $937.
  • Cassaday & Co Wealth Management first reported a position in Revolution Medicines in Q1 2026 and held it in 2 quarters.
  • Cassaday & Co Wealth Management's Revolution Medicines position peaked at $937 in Q2 2026.
  • 756 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.